Science Explorer Back to mapMap
Discussion
Company · Glattbrugg · Switzerland

Vifor Pharma (Switzerland)

In research, Vifor Pharma (Switzerland) stands highest in Health Sciences (#5,440 of 16,688 worldwide) and Medicine (#6,200 of 14,558 worldwide), over all time.

viforpharma.com/enROR OpenAlex
World rank, 2022-now
#19,826
of 22,385 · #19,093 all time
Rank in Switzerland
#157
of 186
Research works
309
▲ 28% vs 2018-21
Citations
6.3k
20.5 per fractional work
Top-10% rate
7.7%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
47%
world 40%
International
55%
world 18%
Vifor Pharma (Switzerland)

What is Vifor Pharma (Switzerland) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #5,440 of 16,688 13.4%175
MedicineField #6,200 of 14,558 13.9%158

Each strip is that field's whole ranked pool, with the notch where Vifor Pharma (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Vifor Pharma (Switzerland) work in?

In 2022-now, 68% of research at Vifor Pharma (Switzerland) is in Health Sciences, 15% in Life Sciences. Its largest fields are Medicine (63%), Agricultural and Biological Sciences (6%), Engineering (4%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 62 fractional works · 67.7% of its workMedicine: 57 fractional works · 62.6% of its workPulmonary and Respiratory Medicine: 9 fractional works · 9.7% of its workHematology: 8 fractional works · 9.2% of its workNephrology: 7 fractional works · 7.3% of its workRheumatology: 5 fractional works · 5.8% of its workDermatology: 5 fractional works · 5.1% of its workCardiology and Cardiovascular Medicine: 4 fractional works · 4.0% of its workSurgery: 3 fractional works · 3.4% of its workGenetics: 3 fractional works · 3.0% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 2.1% of its workPathology and Forensic Medicine: 2 fractional works · 1.9% of its workPhysiology: 2 fractional works · 1.7% of its workEpidemiology: 1 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.0% of its workEmergency Medicine: 1 fractional works · 0.9% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.4% of its workOncology: 0 fractional works · 0.4% of its workTransplantation: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.2% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workPharmacology: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.9% of its workHealth Professions: 3 fractional works · 3.6% of its workGeneral Health Professions: 2 fractional works · 2.0% of its workSpeech and Hearing: 1 fractional works · 1.2% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 1 fractional works · 1.3% of its workNutrition and Dietetics: 1 fractional works · 1.3% of its workDentistry: 0 fractional works · 0.2% of its workLife Sciences: 14 fractional works · 15.5% of its workAgricultural and Biological Sciences: 5 fractional works · 6.0% of its workPlant Science: 4 fractional works · 4.8% of its workInsect Science: 1 fractional works · 0.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 3.7% of its workImmunology: 3 fractional works · 3.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 3.3% of its workMolecular Biology: 1 fractional works · 1.5% of its workStructural Biology: 1 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.4% of its workCognitive Neuroscience: 1 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.0% of its workPharmacology: 1 fractional works · 0.6% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 11 fractional works · 11.9% of its workEngineering: 4 fractional works · 3.9% of its workBiomedical Engineering: 2 fractional works · 2.1% of its workElectrical and Electronic Engineering: 1 fractional works · 1.0% of its workComputational Mechanics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPhysics and Astronomy: 3 fractional works · 3.7% of its workAtomic and Molecular Physics, and Optics: 2 fractional works · 2.4% of its workRadiation: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 2 fractional works · 2.2% of its workSurfaces, Coatings and Films: 1 fractional works · 1.1% of its workBiomaterials: 1 fractional works · 0.9% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 1 fractional works · 0.8% of its workGeochemistry and Petrology: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 0.5% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.1% of its workSocial Sciences: 4 fractional works · 4.9% of its workEconomics, Econometrics and Finance: 3 fractional works · 3.1% of its workEconomics and Econometrics: 3 fractional works · 3.1% of its workSocial Sciences: 1 fractional works · 1.0% of its workSociology and Political Science: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workManagement of Technology and Innovation: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.2% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKVifor Pharma(Switzerland)91fractional works, 2022-now
Life Sciences15%Physical Sciences12%Health Sciences68%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine5762.6%
    2. Health Professions33.6%
    3. Nursing11.3%
    4. Dentistry00.2%
    1. Agricultural and Biological Sciences56.0%
    2. Immunology and Microbiology33.7%
    3. Biochemistry, Genetics and Molecular Biology33.3%
    4. Neuroscience11.4%
    5. Pharmacology, Toxicology and Pharmaceutics11.0%
    1. Engineering43.9%
    2. Physics and Astronomy33.7%
    3. Materials Science22.2%
    4. Earth and Planetary Sciences10.8%
    5. Environmental Science00.5%
    6. Chemistry00.5%
    7. Energy00.2%
    8. Computer Science00.1%
    1. Economics, Econometrics and Finance33.1%
    2. Social Sciences11.0%
    3. Business, Management and Accounting00.3%
    4. Decision Sciences00.2%
    5. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.27× its world share, 6 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.62× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.66× its world share, 3 worksImmunology and Micro…Neuroscience: 0.88× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.86× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.29× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.53× its world share, 1 worksEarth and Planetary …Energy: 0.20× its world share, 0 worksEnergyEngineering: 0.26× its world share, 4 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.64× its world share, 2 worksMaterials SciencePhysics and Astronomy: 1.66× its world share, 3 worksPhysics and AstronomyDentistry: 0.50× its world share, 0 worksDentistryHealth Professions: 1.36× its world share, 3 worksHealth ProfessionsMedicine: 3.26× its world share, 57 worksMedicineNursing: 2.56× its world share, 1 worksNursingBusiness, Management and Accounting: 0.11× its world share, 0 worksBusiness, Management…Decision Sciences: 0.24× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.46× its world share, 3 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.08× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.7×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Immunology and Microbiology3.66×3 works
  2. Medicine3.26×57 works
  3. Pharmacology, Toxicology and Pharmaceutics2.86×1 works
  4. Nursing2.56×1 works
  5. Physics and Astronomy1.66×3 works
  6. Economics, Econometrics and Finance1.46×3 works
  7. Health Professions1.36×3 works
  8. Agricultural and Biological Sciences1.27×6 works
  9. Neuroscience0.88×1 works
  10. Materials Science0.64×2 works
  11. Biochemistry, Genetics and Molecular Biology0.62×3 works
  12. Earth and Planetary Sciences0.53×1 works
  13. Dentistry0.50×0 works
  14. Chemistry0.29×0 works
  15. Engineering0.26×4 works
  16. Decision Sciences0.24×0 works
  17. Energy0.20×0 works
  18. Business, Management and Accounting0.11×0 works
  19. Environmental Science0.10×0 works
  20. Social Sciences0.08×1 works
  21. Psychology0.05×0 works
  22. Computer Science0.02×0 works

Who are the top researchers at Vifor Pharma (Switzerland)?

Ranked on the quality score, Bernard Roubert, Vania Manolova and Franz Dürrenberger lead among researchers whose main affiliation is Vifor Pharma (Switzerland).

  1. 1 Bernard Roubert Switzerland · #440,114 worldwide 3.1k citations · 23 works
  2. 2 Vania Manolova Switzerland · #589,136 worldwide 3.3k citations · 56 works
  3. 3 Franz Dürrenberger Switzerland · #805,525 worldwide 1.3k citations · 34 works
  4. 4 Fabio Dorigotti Switzerland · #1,263,763 worldwide 599 citations · 20 works
  5. 5 Beat Flühmann Switzerland · #1,358,807 worldwide 978 citations · 43 works
  6. 6 Bernard Gabard Switzerland · #1,755,829 worldwide 2k citations · 87 works
  7. 7 Edelgard Anna Kaiser Switzerland · #1,836,535 worldwide 1.6k citations · 23 works
  8. 8 Sandra Waechter Switzerland · #1,841,055 worldwide 510 citations · 36 works
  9. 9 Stefania Ballarini Switzerland · #1,859,478 worldwide 684 citations · 29 works
  10. 10 Philipp Csomor Switzerland · #2,047,221 worldwide 1.2k citations · 46 works
All ranked researchers at Vifor Pharma (Switzerland)

What are the most cited papers from Vifor Pharma (Switzerland)?

The most cited paper from Vifor Pharma (Switzerland) is "Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency" (Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al., 2009), with 2,090 citations. Next come "Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency" (1,245) and "Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial" (797).

Most cited papers
#PaperReleasedCitations
1 Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al. · New England Journal of Medicine Open access 17 Nov 2009 2,090
2 Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Piotr P. Ponikowski, Dirk J. van Veldhuisen, Josep Comín‐Colet et al. · European Heart Journal Open access 31 Aug 2014 1,245
3 Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial Piotr P. Ponikowski et al. · The Lancet Open access210 authors 13 Nov 2020 797
4 Nanomedicines: addressing the scientific and regulatory gap Sally S. Tinkle, Scott E. McNeil, Stefan Mühlebach et al. · Annals of the New York Academy of Sciences 27 Mar 2014 541
5 Azole Fungicides: Occurrence and Fate in Wastewater and Surface Waters Maren Kahle, Ignaz J. Buerge, Andrea Hauser et al. · Environmental Science & Technology 27 Aug 2008 457
All 60 most cited papers, with filters and sorting

Which keywords describe research at Vifor Pharma (Switzerland)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Heart Failure, Chronic Kidney Disease, Inflammation, Diagnosis, Cardiovascular Disease, Anemia, Iron Deficiency and Erythropoiesis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Heart Failure10▲ 25×9 topics
  2. Chronic Kidney Disease10▲ 45×6 topics
  3. Inflammation10▲ 5.2×21 topics
  4. Epidemiology10▲ 2.7×22 topics
  5. Diagnosis8▲ 9.6×10 topics
  6. Cardiovascular Disease8▲ 7.7×13 topics
  7. Anemia8▲ 85×4 topics
  8. Iron Deficiency7▲ 141×2 topics
  9. Quality of Life6▲ 5.0×8 topics
  10. Oxidative Stress6▲ 4.3×12 topics
  11. Erythropoiesis6▲ 112×2 topics
  12. Treatment6▲ 5.6×10 topics
  13. Hepcidin5▲ 149×1 topic
  14. Iron Regulation5▲ 149×1 topic
  15. Immune Dysregulation5▲ 72×2 topics
  16. Hyperkalemia5▲ 369×1 topic
  17. Renin-Angiotensin-Aldosterone System Inhibitors5▲ 369×1 topic
  18. Management5▲ 6.6×7 topics
  19. Autoantibodies5▲ 22×6 topics
  20. Filaggrin4▲ 97×1 topic
  21. Skin Microbiome4▲ 97×1 topic
  22. Guidelines4▲ 9.7×4 topics
  23. Glomerular Diseases3▲ 99×1 topic
  24. Nephrotic Syndrome3▲ 99×1 topic
  25. Autoimmune3▲ 65×2 topics
  26. TGF-ß3▲ 19×2 topics
  27. Immune System3▲ 12×4 topics
  28. Rituximab3▲ 20×2 topics
  29. B-Type Natriuretic Peptide2▲ 54×1 topic
  30. Chronic Spontaneous Urticaria2▲ 131×1 topic
  31. Hospital Readmission2▲ 54×1 topic
  32. Nutrition2▲ 6.3×3 topics
  33. Primary Care2▲ 7.3×4 topics
  34. Urticaria2▲ 131×1 topic
  35. ANCA-associated2▲ 101×1 topic
  36. Clinical Features2▲ 71×2 topics
  37. Vasculitides2▲ 101×1 topic
  38. Sickle-cell Disease2▲ 58×1 topic
  39. Thalassemia2▲ 58×1 topic
  40. Chronic Conditions2▲ 34×2 topics

Which research topics does Vifor Pharma (Switzerland) publish most on?

By volume in 2022-now: Iron Metabolism and Disorders, Potassium and Related Disorders, Dermatology and Skin Diseases and Renal Diseases and Glomerulopathies.

Iron Metabolism and Disorders: 5 fractional worksPotassium and Related Disorders: 5 fractional worksDermatology and Skin Dis…4Dermatology and Skin Diseases: 4 fractional worksRenal Diseases and Glome…3Renal Diseases and Glomerulopathies: 3 fractional worksUrticaria and Related Conditions: 2 fractional worksHeart Failure Treatment and Management: 2 fractional worksVasculitis and related c…2Vasculitis and related conditions: 2 fractional worksHemoglobinopathies and Related Disorders: 2 fractional worksPsoriasis: Treatment and Pathogenesis: 2 fractional worksOtitis Media and Relapsing Polychondritis: 2 fractional works
HematologyPulmonary and Respiratory MedicineDermatologyNephrology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Iron Metabolism and Disorders Hematology 5 works
  2. 2 Potassium and Related Disorders Pulmonary and Respiratory Medicine 5 works
  3. 3 Dermatology and Skin Diseases Dermatology 4 works
  4. 4 Renal Diseases and Glomerulopathies Nephrology 3 works
  5. 5 Urticaria and Related Conditions Rheumatology 2 works
  6. 6 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 2 works
  7. 7 Vasculitis and related conditions Pulmonary and Respiratory Medicine 2 works
  8. 8 Hemoglobinopathies and Related Disorders Genetics 2 works
  9. 9 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  10. 10 Otitis Media and Relapsing Polychondritis Rheumatology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.0%not open53.0%

World: 40% of research is openly available.

with international co-authors54.6%domestic only45.4%

World: 18% is written across borders.

How has Vifor Pharma (Switzerland)'s research output changed?

Output in 2022-2025 was 28% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vifor Pharma (Switzerland) as a percentage of every work published that year, 0.00036% in 2024.

still counting0.00020%0.00040%0.00060%Vifor Pharma (Switzerland)0.00029% in 202519801990200020102020

Fractional works of Vifor Pharma (Switzerland) over all fractional works that year. How the balance of science has shifted.

Share Vifor Pharma (Switzerland)'s ranking

Vifor Pharma (Switzerland) on Science Explorer

A card with Vifor Pharma (Switzerland)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vifor Pharma (Switzerland). Posts are plain text and can be reported.